journal article·2009-04

PLGA doping of PCL affects the plastic potential of human mesenchymal stem cells, both in the presence and absence of biological stimuli

J. M. Curran, Z. Tang, J. A. Hunt

Publisher page

Abstract

Abstract A range of poly ϵ‐caprolactone (PCL) films mixed/doped with poly(lactide‐co‐glycolide) (PLGA) (65:35) in 0, 10, 20, and 30 wt % were produced, sterilized using ethylene oxide, and analyzed using FTIR. Characterized human mesenchymal stem cells (hMSCs) were cultured in contact with the materials in basal, chondrogenic, and osteogenic medium for time periods up to 28 days, to determine if the materials could induce differentiation of MSC both in the presence and absence of biological stimuli. Viable cell adhesion was analyzed under all conditions. Collagen I, collagen II, sox‐9, osteocalcin, osteopontin, osteonectin, and CBFA1 were evaluated at both the mRNA (real‐time PCR) and protein production levels (fluorescent immunohistochemistry) and used to identify cell differentiation. Pure PCL and PCL mixed with PLGA demonstrated a chondrogenic potential. Only PCL 8 (80 wt % PCL, 20 wt % PLGA) facilitated osteogenic differentiation of MSCs under osteogenic conditions. This was attributed to the increased hydrophilic nature of the surface allowing sufficient homogeneous cell attachment and the formation of filamentous F‐actin in the cells, allowing osteogenic differentiation. Of all materials tested, PCL 7 (70 wt % PCL, 30 wt % PLGA) demonstrated the greatest chondrogenic differentiation potential under basal and stimulated conditions at both the mRNA and protein production level. © 2008 Wiley Periodicals, Inc. J Biomed Mater Res, 2009
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Bone Tissue Engineering Materials · Orthopaedic implants and arthroplasty · biodegradable polymer synthesis and properties

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (20)

Show source-provided references
1. 10.1016/j.tibtech.2005.10.00610.1016/j.tibtech.2005.10.006 ↗
2. 10.1016/0142-9612(91)90037-B10.1016/0142-9612(91)90037-B ↗
3. Evaluation of a tissue‐engineered membrane‐cell construct for guided bone regeneration
4. 10.1016/0142-9612(96)85570-010.1016/0142-9612(96)85570-0 ↗
5. 10.1016/S0169-409X(03)00037-110.1016/S0169-409X(03)00037-1 ↗
6. 10.1002/1097-4636(200011)52:2<279::AID-JBM6>3.0.CO;2-810.1002/1097-4636(200011)52:2<279::AID-JBM6>3.0.CO;2-8 ↗
7. 10.1016/S0142-9612(02)00158-810.1016/S0142-9612(02)00158-8 ↗
8. 10.1016/j.biomaterials.2004.11.04710.1016/j.biomaterials.2004.11.047 ↗
9. 10.1089/ten.2006.12.9110.1089/ten.2006.12.91 ↗
10. 10.1016/j.biomaterials.2003.12.00310.1016/j.biomaterials.2003.12.003 ↗
11. 10.1016/j.biomaterials.2005.04.01310.1016/j.biomaterials.2005.04.013 ↗
12. 10.1016/j.biomaterials.2006.04.00910.1016/j.biomaterials.2006.04.009 ↗
13. 10.1177/15353702012260060310.1177/153537020122600603 ↗
14. 10.1016/j.biomaterials.2005.05.00810.1016/j.biomaterials.2005.05.008 ↗
15. 10.1016/j.biomaterials.2006.05.00110.1016/j.biomaterials.2006.05.001 ↗
16. 10.1096/fj.02-0940com10.1096/fj.02-0940com ↗
17. 10.1016/j.jcis.2004.02.00110.1016/j.jcis.2004.02.001 ↗
18. 10.1016/j.biomaterials.2006.10.02710.1016/j.biomaterials.2006.10.027 ↗
19. 10.1016/S1534-5807(04)00075-910.1016/S1534-5807(04)00075-9 ↗
20. 10.1359/JBMR.05061110.1359/JBMR.050611 ↗